DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+8.78%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$44.5B
AUM Growth
+$4.78B
(+12%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.04%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,360
New
50
Increased
563
Reduced
449
Closed
104
Top Buys
| 1 |
Procter & Gamble
PG
|
+$93.7M |
| 2 |
Parker-Hannifin
PH
|
+$83.7M |
| 3 |
Deere & Co
DE
|
+$81.8M |
| 4 |
Abbott
ABT
|
+$81.2M |
| 5 |
Emerson Electric
EMR
|
+$75M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$214M |
| 2 |
Broadcom
AVGO
|
+$72M |
| 3 |
Palo Alto Networks
PANW
|
+$62.8M |
| 4 |
Marvell Technology
MRVL
|
+$56.1M |
| 5 |
UBS Group
UBS
|
+$53M |
Sector Composition
| 1 | Technology | 28.46% |
| 2 | Healthcare | 17.84% |
| 3 | Industrials | 10.35% |
| 4 | Financials | 10.06% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
AbCellera Biologics
ABCL
$1.38B
| $571K | ﹤0.01% |
87,000
| – | – |
|
1002
Janux Therapeutics
JANX
$1.48B
| $571K | ﹤0.01% |
49,500
| – | – |
|
1003
Macerich
MAC
$4.57B
| $570K | ﹤0.01% |
50,946
-3,217
| -6% | -$36K |
|
1004
Syndax Pharmaceuticals
SNDX
$1.38B
| $568K | ﹤0.01% |
28,300
| – | – |
|
1005
Arrow Electronics
ARW
$6.56B
| $548K | ﹤0.01% |
3,863
-7,803
| -67% | -$1.11M |
|
1006
Maravai LifeSciences
MRVI
$392M
| $547K | ﹤0.01% |
44,000
| – | – |
|
1007
Ormat Technologies
ORA
$5.58B
| $545K | ﹤0.01% |
6,846
-1,811
| -21% | -$144K |
|
1008
Varonis Systems
VRNS
$6.35B
| $545K | ﹤0.01% |
20,500
-1,170
| -5% | -$31.1K |
|
1009
Chewy
CHWY
$14.8B
| $543K | ﹤0.01% |
14,150
+2,156
| +18% | +$82.7K |
|
1010
Bombardier Recreational Products
DOOO
$4.74B
| $533K | ﹤0.01% |
6,562
+2,878
| +78% | +$234K |
|
1011
Four Corners Property Trust
FCPT
$2.67B
| $530K | ﹤0.01% |
20,951
-363
| -2% | -$9.18K |
|
1012
Hyatt Hotels
H
$13.9B
| $529K | ﹤0.01% |
+4,700
| New | +$529K |
|
1013
Tanger
SKT
$3.9B
| $528K | ﹤0.01% |
23,981
-1,693
| -7% | -$37.3K |
|
1014
ImmunityBio
IBRX
$2.45B
| $527K | ﹤0.01% |
196,200
| – | – |
|
1015
Arvinas
ARVN
$591M
| $522K | ﹤0.01% |
20,000
| – | – |
|
|
ABST
1016
DELISTED
Absolute Software Corporation Common Stock
ABST
| $522K | ﹤0.01% |
46,000
-3,300
| -7% | -$37.4K |
|
1017
Descartes Systems
DSGX
$9.09B
| $518K | ﹤0.01% |
6,650
+1,332
| +25% | +$104K |
|
|
AZPN
1018
DELISTED
Aspen Technology Inc
AZPN
| $518K | ﹤0.01% |
3,142
-614
| -16% | -$101K |
|
1019
Douglas Emmett
DEI
$2.83B
| $514K | ﹤0.01% |
40,638
-2,854
| -7% | -$36.1K |
|
1020
BioCryst Pharmaceuticals
BCRX
$1.69B
| $512K | ﹤0.01% |
73,765
| – | – |
|
1021
Reinsurance Group of America
RGA
$12.7B
| $511K | ﹤0.01% |
3,687
| – | – |
|
1022
Ocular Therapeutix
OCUL
$2.23B
| $505K | ﹤0.01% |
100,000
+75,000
| +300% | +$379K |
|
1023
Alcoa
AA
$8.22B
| $503K | ﹤0.01% |
15,015
+411
| +3% | +$13.8K |
|
1024
Sunstone Hotel Investors
SHO
$1.79B
| $500K | ﹤0.01% |
49,529
-3,631
| -7% | -$36.7K |
|
1025
Arcellx
ACLX
$4.19B
| $499K | ﹤0.01% |
16,000
| – | – |
|